A specific new biomarker for atrial fibrillation and its sequelae?

Moritz F Sinner^{1

2}, Aenne S von Falkenhausen^{1

2}

Affiliations

¹ Department of Cardiology, University Hospital, LMU Munich, Germany.
² German Centre for Cardiovascular Research (DZHK), Partner site: Munich Heart Alliance, Munich, Germany.

Editorial

Moritz F Sinner et al. Eur Heart J. 2023.

. 2023 Jan 14;44(3):219-220.

doi: 10.1093/eurheartj/ehac645.

Moritz F Sinner^{1

2}, Aenne S von Falkenhausen^{1

2}

¹ Department of Cardiology, University Hospital, LMU Munich, Germany.
² German Centre for Cardiovascular Research (DZHK), Partner site: Munich Heart Alliance, Munich, Germany.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
Hijazi Z, Benz AP, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Granger CB, Kastner P, Lopes RD, Ziegler A, Oldgren J, Siegbahn A, Wallentin L. Hijazi Z, et al. Eur Heart J. 2023 Jan 14;44(3):208-218. doi: 10.1093/eurheartj/ehac632. Eur Heart J. 2023. PMID: 36380569 Free PMC article.